Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             121 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Aberrant upregulation of a novel integrin α subunit gene at 3p21.3 in small cell lung cancer 1994
 11 3-4 p. 326-
1 p.
 artikel
2 A case of minimal size small cell carcinoma arising in abnormal branching bronchus with mycobacteriosis 1994
 11 3-4 p. 330-
1 p.
 artikel
3 A case of successful curative operation followed by neoadjuvant chemotherapy for stage cIIIA epidermoid carcinoma of the lung 1994
 11 3-4 p. 343-344
2 p.
 artikel
4 A clinical analysis of small-sized lung cancer with advanced disease 1994
 11 3-4 p. 330-
1 p.
 artikel
5 Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas 1994
 11 3-4 p. 328-
1 p.
 artikel
6 Altered subcellular distribution of topoisomerase IIα in a drug-resistant human small cell lung cancer cell line 1994
 11 3-4 p. 341-
1 p.
 artikel
7 Analysis of prognostic factors of patients with small cell lung cancer using Cox's proportional hazards model 1994
 11 3-4 p. 330-
1 p.
 artikel
8 A new variation of tracheobronchoplastic operation 1994
 11 3-4 p. 335-
1 p.
 artikel
9 A patient with D2 lung cancer surviving for nine years following resection and chemotherapy 1994
 11 3-4 p. 343-
1 p.
 artikel
10 A phase II trial of alternating chemotherapy in patients with inoperable non-small cell lung cancer 1994
 11 3-4 p. 341-
1 p.
 artikel
11 A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer 1994
 11 3-4 p. 343-
1 p.
 artikel
12 Are the apparent effects of cigarette smoking on lung and bladder cancers due to uncontrolled confounding by occupational exposures? 1994
 11 3-4 p. 324-
1 p.
 artikel
13 Asbestos exposure according to different exposure indices among Finnish lung cancer patients 1994
 11 3-4 p. 325-
1 p.
 artikel
14 A 10-year incidence survey of respiratory cancer and a case-control study within a cohort of nickel mining and refining workers in New Caledonia 1994
 11 3-4 p. 325-
1 p.
 artikel
15 Biologic and clinical effects of continuous infusion interleukin-2 in patients with non-small cell lung cancer 1994
 11 3-4 p. 341-342
2 p.
 artikel
16 Bone marrow scintigraphy in small cell carcinoma of the lung 1994
 11 3-4 p. 331-
1 p.
 artikel
17 Bronchiectasis with concomitant lung cancer. A report of 7 cases 1994
 11 3-4 p. 331-332
2 p.
 artikel
18 Calcitonin elevation in small cell lung cancer without ectopic production 1994
 11 3-4 p. 332-
1 p.
 artikel
19 Carboplatin and etoposide as outpatient treatment of advanced non-small cell lung cancer 1994
 11 3-4 p. 339-
1 p.
 artikel
20 Carboplatin (CBDCA) plus alpha interferon in metastatic non-small cell lung cancer: A Hoosier Oncology Group Phase II trial 1994
 11 3-4 p. 335-
1 p.
 artikel
21 Carcinoid crisis after biopsy of a bronchial carcinoid 1994
 11 3-4 p. 330-
1 p.
 artikel
22 C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas 1994
 11 3-4 p. 333-
1 p.
 artikel
23 Choroidal metastasis revealing a bronchial adenocarcinoma in a 36 year old woman 1994
 11 3-4 p. 329-
1 p.
 artikel
24 Cigarette smoking and lung cancer: A reconsideration of the British doctors' data with cumulative damage models 1994
 11 3-4 p. 323-324
2 p.
 artikel
25 Cisplatin—5-fluorouracil in small cell lung cancer. A Phase II study in 109 patients Morere, Jean F.
 1994
 11 3-4 p. 275-281
7 p.
 artikel
26 Cisplatin-VP16 alternating with cyclophosphamide-epirubicin versus cyclophosphamide-epirubicin-vincristine in small cell lung cancer 1994
 11 3-4 p. 335-
1 p.
 artikel
27 Combination chemotherapy with carboplatn and etoposide against lung adenocarcinoma in a patient undergoing hemodialysis: A case report 1994
 11 3-4 p. 339-
1 p.
 artikel
28 Combination chemotherapy with cisplatin-vinblastine in malignant mesothelioma Tsavaris, Nicolas
 1994
 11 3-4 p. 299-303
5 p.
 artikel
29 Combination chemotherapy with cyclophosphamide, epirubicin and etoposide in small cell lung cancer Jassem, J.
 1994
 11 3-4 p. 283-291
9 p.
 artikel
30 Combination therapy of small cell lung cancer with teniposide, ifosfamide and carboplatin 1994
 11 3-4 p. 338-
1 p.
 artikel
31 Comparative study of the antitumor activity of bistramides A, D and K against a non-small cell broncho-pulmonary carcinoma 1994
 11 3-4 p. 338-
1 p.
 artikel
32 Constitutive production of multiple colony-stimulting factors in patients with lung cancer associated with neutrophilia 1994
 11 3-4 p. 337-
1 p.
 artikel
33 Cytometric validation of immunocytochemical observations in developing lung cancer 1994
 11 3-4 p. 328-
1 p.
 artikel
34 Debrisoquin oxidation genotype and susceptibility to lung cancer 1994
 11 3-4 p. 327-
1 p.
 artikel
35 Detection of lymph node metastases in lung cancer: comparison of 131I-Anti-CEA-Anti-CA 19-9 immunoscintigraphy versus computed tomography Boilleau, Geneviève
 1994
 11 3-4 p. 209-219
11 p.
 artikel
36 Dextromethorphan test for evaluation of congenital predisposition to lung cancer 1994
 11 3-4 p. 323-
1 p.
 artikel
37 Directional selection associated with clonal expansion of p53 mutant cells during neoplastic development of carcinogen-treated rat embryo lung epithelial cells 1994
 11 3-4 p. 326-
1 p.
 artikel
38 DNA stemline heterogeneity of non-small cell lung carcinomas and differences in DNA ploidy between carcinomas and metastatic nodes Ayabe, Hiroyoshi
 1994
 11 3-4 p. 201-208
8 p.
 artikel
39 Endobronchial mucosal bridges as evidence of residual malignancy 1994
 11 3-4 p. 330-
1 p.
 artikel
40 Extended resection for higher-stage non-small-cell lung cancer 1994
 11 3-4 p. 333-
1 p.
 artikel
41 Fetal isoform of human retinoic acid receptor β expressed in small cell lung cancer lines 1994
 11 3-4 p. 327-
1 p.
 artikel
42 Genes of laminin B1 chain, α1 (IV) chain of type IV collagen, and 72-kd type IV collagenase are mainly expressed by the stromal cells of lung carcinomas 1994
 11 3-4 p. 327-
1 p.
 artikel
43 Glutathione and glutathione linked enzymes in human small cell lung cancer cell lines 1994
 11 3-4 p. 335-336
2 p.
 artikel
44 High dose doxorubicin plus cisplatin in the treatment of unresectable mesotheliomas: report of four cases Stewart, David J.
 1994
 11 3-4 p. 251-258
8 p.
 artikel
45 Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic finger printing 1994
 11 3-4 p. 325-326
2 p.
 artikel
46 IASLC calendar 1994
 11 3-4 p. 321-
1 p.
 artikel
47 IASLC conference 1994
 11 3-4 p. 315-317
3 p.
 artikel
48 Immunohistochemical detection of carcinoembryonic antigen (CEA) in non- neoplastic lung disease 1994
 11 3-4 p. 329-
1 p.
 artikel
49 Immunotoxins recognising a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer 1994
 11 3-4 p. 337-
1 p.
 artikel
50 Inability of serum neuron-specific enolase to predict disease extent in small cell lung cancer 1994
 11 3-4 p. 331-
1 p.
 artikel
51 Indications for an expandable metallic stent for tracheobronchial stenosis 1994
 11 3-4 p. 334-
1 p.
 artikel
52 Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer 1994
 11 3-4 p. 343-
1 p.
 artikel
53 Inhibitory effects of cholera toxin on in vitro growth of human lung cancer cell lines 1994
 11 3-4 p. 337-
1 p.
 artikel
54 Interest of C-reactive protein assay in small cell lung cancer 1994
 11 3-4 p. 328-
1 p.
 artikel
55 In vitro and in vivo expressions of transforming growth factor-α and tyrosine kinase receptors in human non-small-cell lung carcinomas 1994
 11 3-4 p. 327-
1 p.
 artikel
56 Isolation and in vitro expansion of lymphocytes infiltrating non-small cell lung carcinoma: Functional and molecular characterisation for their use in adoptive immunotherapy 1994
 11 3-4 p. 331-
1 p.
 artikel
57 Less than lobar restrictions for bronchogenic carcinoma 1994
 11 3-4 p. 335-
1 p.
 artikel
58 Local recurrence after complete resection for non-small-cell carcinoma of the lung: Significance of local control by radiation treatment 1994
 11 3-4 p. 334-
1 p.
 artikel
59 Lung cancer morbidity in the population of the Norilsk industrial region 1994
 11 3-4 p. 323-
1 p.
 artikel
60 Lung cancer with extra pulmonary symptoms as the chief manifestation. A clinical analysis of 47 cases 1994
 11 3-4 p. 331-
1 p.
 artikel
61 Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer 1994
 11 3-4 p. 333-334
2 p.
 artikel
62 Malignant epithelial mesothelioma presenting as cardiac tamponade 1994
 11 3-4 p. 328-
1 p.
 artikel
63 Management of patients with small cell carcinoma and the syndrome of ectopic corticotropin secretion 1994
 11 3-4 p. 332-333
2 p.
 artikel
64 ME1-Antibody labelling of primary bronchogenic tumours and extrapulmonary malignancies Skov, Birgit Guldhammer
 1994
 11 3-4 p. 221-227
7 p.
 artikel
65 Mediastinal invasion by bronchogenic carcinoma: CT signs 1994
 11 3-4 p. 332-
1 p.
 artikel
66 Metachronous lung carcinoma 1994
 11 3-4 p. 329-330
2 p.
 artikel
67 Mutational spectrum of the p53 gene in human small-cell lung cancer and relationship to clinicopathological data 1994
 11 3-4 p. 332-
1 p.
 artikel
68 Neoadjuvant and adjuvant therapy in the management of locally advanced non-small-cell lung cancer 1994
 11 3-4 p. 342-
1 p.
 artikel
69 New perspectives in lung cancer Sörenson, Sverre
 1994
 11 3-4 p. 319-320
2 p.
 artikel
70 New trends in treatment of small-cell lung-cancer 1994
 11 3-4 p. 344-
1 p.
 artikel
71 Phase I/II and pharmacologic study of long-term continuous infusion etoposide combined with cisplatin in patients with advanced non-small-cell lung cancer 1994
 11 3-4 p. 336-
1 p.
 artikel
72 Phase II randomized trial comparing high-dose cisplatin with moderate- dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer 1994
 11 3-4 p. 340-
1 p.
 artikel
73 Phase II study of 4′-iodo-4′-deoxydoxorubicin in patients with advanced, measurable non-small cell lung cancer 1994
 11 3-4 p. 341-
1 p.
 artikel
74 Phase II study of topotecan in metastatic non-small-cell lung cancer 1994
 11 3-4 p. 340-
1 p.
 artikel
75 Phase II trials of malignant mesothelioma: A commentary and update Krarup-Hansen, Anders
 1994
 11 3-4 p. 305-308
4 p.
 artikel
76 Phase I study of irinotecan and cisplatin with granulocyte colony- stimulating factor support for advanced non-small-cell lung cancer 1994
 11 3-4 p. 336-337
2 p.
 artikel
77 Phenotypied, molecular and genetic characterization of transformed human bronchial epithelial cell strains 1994
 11 3-4 p. 324-325
2 p.
 artikel
78 p53 Mutation hotspot in radon-associated lung cancer 1994
 11 3-4 p. 323-
1 p.
 artikel
79 p53 Mutations in lung cancer from non-smoking atomic-bomb survivors 1994
 11 3-4 p. 323-
1 p.
 artikel
80 Postoperative chemotherapy for resected non-small-cell lung cancer 1994
 11 3-4 p. 342-
1 p.
 artikel
81 Problems of inference from hypothesis-generating studies on lung cancer and occupation based on routine hospital records 1994
 11 3-4 p. 324-
1 p.
 artikel
82 Pulmonary hamartoma and malignancy 1994
 11 3-4 p. 332-
1 p.
 artikel
83 Pulmonary infections in lung cancer patients at diagnosis Putinati, Stefano
 1994
 11 3-4 p. 243-249
7 p.
 artikel
84 Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients 1994
 11 3-4 p. 340-341
2 p.
 artikel
85 Received dose-intensity: A randomized trial of weekly chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer 1994
 11 3-4 p. 336-
1 p.
 artikel
86 Recent trends in the management of lung cancer 1994
 11 3-4 p. 309-314
6 p.
 artikel
87 Review of the curative role of radiotherapy in the treatment of non-small cell lung cancer Damstrup, L.
 1994
 11 3-4 p. 153-178
26 p.
 artikel
88 Risk factors for lung cancer in Rio de Janeiro, Brazil: a case-control study Suzuki, Iunis
 1994
 11 3-4 p. 179-190
12 p.
 artikel
89 Scintigraphic detection of neural-cell-derived small-cell lung cancer using glioma-specific antibody 1994
 11 3-4 p. 327-328
2 p.
 artikel
90 Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: Results of a North Central Cancer Treatment Group randomized clinical trial 1994
 11 3-4 p. 336-
1 p.
 artikel
91 Serum and tissue levels of CEA, TPA, CA 125 and CA 15.3 in patients with lung cancer 1994
 11 3-4 p. 329-
1 p.
 artikel
92 Simultaneous occurrence of three primary lung cancers 1994
 11 3-4 p. 332-
1 p.
 artikel
93 Smoking of hand-rolled cigarettes as a risk factor for small cell lung cancer in men: a case-control study from Uruguay De Stéfani, Eduardo
 1994
 11 3-4 p. 191-199
9 p.
 artikel
94 Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor 1994
 11 3-4 p. 329-
1 p.
 artikel
95 Staging and management of lung cancer: Sleeve resection 1994
 11 3-4 p. 333-
1 p.
 artikel
96 Suramin inhibits the phosphorylation and catalytic activity of DNA topoisomerase II in human lung cancer cells 1994
 11 3-4 p. 338-
1 p.
 artikel
97 Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease) 1994
 11 3-4 p. 334-335
2 p.
 artikel
98 Surgical treatment of lung cancer in the octogenarian 1994
 11 3-4 p. 334-
1 p.
 artikel
99 Survival of noncuratively resected lung cancer Kimura, Hideki
 1994
 11 3-4 p. 229-242
14 p.
 artikel
100 TGFα-PE40 inhibits non-small cell lung cancer growth Draoui M, Siegall CB, FitzGerald D, Pastan I, Moody TW. Dept. Biochemistry/Molecular Biology, George Washington University, Sch. of Medicine and Health Sciences, Washington, DC 20037. Life Sci 1994;54:445–453 1994
 11 3-4 p. 340-
1 p.
 artikel
101 The immunomodulating effect of indometacin in the course of chemoradiation treatment for inoperable lung cancer 1994
 11 3-4 p. 343-
1 p.
 artikel
102 The impact of therapy with filgrastim (recombinant granulocyte colony-stimulating factor) on the health care cost associated with cancer chemotherapy 1994
 11 3-4 p. 338-339
2 p.
 artikel
103 The long term outcome after radical radiotherapy for advanced localized non-small cell carcinoma of the lung 1994
 11 3-4 p. 342-
1 p.
 artikel
104 The prognostic significance of bone marrow metastases in small cell lung cancer patients 1994
 11 3-4 p. 329-
1 p.
 artikel
105 The reirradiation of recurrent bronchogenic carcinoma with external beam irradiation 1994
 11 3-4 p. 342-
1 p.
 artikel
106 The results of surgical treatment of non-small cell lung cancer at the Pneumological Clinic in Prague, Czech Republic 1985–1990 Marel, M.
 1994
 11 3-4 p. 293-298
6 p.
 artikel
107 The risk of lung cancer from asbestos among Swedish construction workers: Self-reported exposure and a job exposure matrix compared 1994
 11 3-4 p. 324-
1 p.
 artikel
108 The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies 1994
 11 3-4 p. 339-
1 p.
 artikel
109 The significance of HLA typing in lung cancer patients, in relation to disease susceptibility, relapse and survival 1994
 11 3-4 p. 330-
1 p.
 artikel
110 Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: Chemistry, biochemistry, carcinogenicity, and relevance to humans 1994
 11 3-4 p. 325-
1 p.
 artikel
111 Tracheal sleeve pneumonectomy for bronchogenic carcinoma 1994
 11 3-4 p. 334-
1 p.
 artikel
112 Transthoracic needle biopsy 1994
 11 3-4 p. 328-329
2 p.
 artikel
113 Treatment and prognosis in bronchial carcinoids involving regional lymph nodes 1994
 11 3-4 p. 331-
1 p.
 artikel
114 Treatment of non-small cell lung cancer: New cytostatic agents 1994
 11 3-4 p. 338-
1 p.
 artikel
115 Treatment of small-cell lung cancer xenografts with iodine-131-anti-neural cell adhesion molecular monoclonal antibody and evaluation of absorbed dose in tissue 1994
 11 3-4 p. 339-
1 p.
 artikel
116 Treatment of unresectable non-small cell lung cancer (NSCLC) with carboplatin and chronic daily administration of oral etoposide 1994
 11 3-4 p. 341-
1 p.
 artikel
117 Treatment-related deaths in small cell lung cancer trials: can patients at risk be identified? Stephens, R.J.
 1994
 11 3-4 p. 259-274
16 p.
 artikel
118 Tumor markers and oncogenes in lung cancer 1994
 11 3-4 p. 326-
1 p.
 artikel
119 Urinary-derived monocyte-colony stimulating factor (P-100) following treatment with carboplatin and etoposide in small cell lung cancer (SCLC) 1994
 11 3-4 p. 337-338
2 p.
 artikel
120 Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma 1994
 11 3-4 p. 326-327
2 p.
 artikel
121 Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial 1994
 11 3-4 p. 339-340
2 p.
 artikel
                             121 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland